Diabetes-focused medical device specialist DexCom (NASDAQ: DXCM) has been successful thanks to its continuous glucose monitoring (CGM) devices that allow diabetes patients to check their blood glucose levels in real time. While the growing adoption of this technology has generally bolstered its revenue, the company's top-line growth rates have dropped of late. How will the next 12 months go for DexCom?